Envoy Medical Inc.
COCH | NASDAQ
$0.72
+$0.01 (+1.34%)
Sep 22, 2026, 2:42 PM ET · Market open
Market Data
Market Cap $14.78M
Enterprise Value $-4.09M
Beta 1.90
Average Volume 299.67K
Shares Outstanding (Diluted) 104.04M
Shares Change YoY 430.81%
Institutional Ownership 25.08%
Exchange NASDAQ
ISIN US29415V1098
Price Performance
Price Change 1M -5.3%
Price Change 3M 9.2%
Price Change 6M 3.8%
Price Change YTD 2.1%
Price Change 1Y -24.8%
Price Change 3Y -93.2%
Price Change 5Y -92.7%
1M CAGR (ann.) 5.9%
1Y CAGR (ann.) -48.1%
5Y CAGR (ann.) -40.8%
All-Time CAGR -38.4%
Valuation
PE Ratio -1.06
Forward PE N/A
PEG Ratio -0.01
Forward PEG 0.04
PS Ratio 71.39
Forward PS 147.80
PB Ratio 4.47
P/FCF Ratio -0.68
P/Adj. FCF Ratio -0.66
P/OCF Ratio -3.38
EV/Sales -19.76
EV/EBIT 0.18
EV/EBITDA 0.18
EV/FCF 0.19
Earnings Yield -94.4%
FCF Yield -146.9%
Adj. FCF Yield -150.9%
Financial Health
Net Cash $19.68M
Total Debt $810K
Cash & Short-Term Investments $19.68M
Total Assets $23.95M
Current Ratio 1.73
Quick Ratio 1.61
Debt / Equity Ratio 0.25
Debt / EBITDA -0.04
Debt / FCF -0.04
OCF / Debt -26.58
Interest Coverage -50.15
Altman Z-Score -21.34
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin -385.5%
Operating Profit Margin -11411.1%
EBITDA Margin -10567.6%
Net Profit Margin -11304.8%
FCF Margin -10488.4%
Adj. FCF Margin -10775.4%
SBC / Revenue 287.0%
SBC Impact (per share) -2.7%
Returns
Return on Assets -97.7%
Return on Equity 1719.7%
Return on Invested Capital -206.3%
Return on Capital Employed -208.8%
Return on Tangible Assets -97.7%
Historical Growth (CAGR)
Revenue CAGR 3Y -1.7%
Revenue CAGR 5Y 4.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 9.9%
EPS CAGR 5Y 0.0%
EPS CAGR 10Y N/A
FCF CAGR 3Y -0.5%
FCF CAGR 5Y -22.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 3
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y 658.7%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.07
EPS Growth Est (next Q) -80.0%
Revenue Est (next Q) $50K
Revenue Growth Est (next Q) 19.1%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $2
Price Target Upside 181.7%
Cash Flow
Operating Cash Flow $-21.53M
Free Cash Flow $-21.71M
Adj. Free Cash Flow $-22.31M
FCF Per Share -$0.21
OCF Per Share -$0.21
OCF/S Ratio -10402.4%
Income Statement
Revenue $207K
Gross Profit $-798K
Operating Income $-23.62M
EBITDA $-22.63M
Net Income $-23.4M
EPS (Diluted) -$0.67
Revenue / Employee $4.81K
Profit / Employee $-544.21K
Employees 43
Add to Watchlist
Select watchlists to add or remove COCH